Jessica Pagano

Via Follereau 3, Vedano Al Lambro
Milan, 20854, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study.

SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study.

Journal: Translational psychiatry

Published: June 22, 2025

Shank3 deletion in PV neurons is associated with abnormal behaviors and neuronal functions that are rescued by increasing GABAergic signaling.

Shank3 deletion in PV neurons is associated with abnormal behaviors and neuronal functions that are rescued by increasing GABAergic signaling.

Journal: Molecular autism

Published: December 11, 2022

Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports.

Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports.

Journal: Journal of personalized medicine

Published: August 16, 2022

Deletion of calcineurin from astrocytes reproduces proteome signature of Alzheimer's disease and epilepsy and predisposes to seizures.

Deletion of calcineurin from astrocytes reproduces proteome signature of Alzheimer's disease and epilepsy and predisposes to seizures.

Journal: Cell calcium

Published: August 15, 2021

The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease.

The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 25, 2021

Another step toward understanding brain functional connectivity alterations in autism: An Editorial Highlight for "Neurobiological substrates underlying corpus callosum hypoconnectivity and brain metabolic patterns in the valproic acid rat model of autism spectrum disorder" on page 128.

Another step toward understanding brain functional connectivity alterations in autism: An Editorial Highlight for "Neurobiological substrates underlying corpus callosum hypoconnectivity and brain metabolic patterns in the valproic acid rat model of autism spectrum disorder" on page 128.

Journal: Journal of neurochemistry

Published: April 30, 2021

N-methyl-d-aspartate receptor function in neuronal and synaptic development and signaling.

N-methyl-d-aspartate receptor function in neuronal and synaptic development and signaling.

Journal: Current opinion in pharmacology

Published: September 10, 2020

Activation of the medial preoptic area (MPOA) ameliorates loss of maternal behavior in a Shank2 mouse model for autism.

Activation of the medial preoptic area (MPOA) ameliorates loss of maternal behavior in a Shank2 mouse model for autism.

Journal: The EMBO journal

Published: December 15, 2019

Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice.

Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice.

Journal: Molecular psychiatry

Published: October 25, 2019

The Up and Down of the N-Methyl-D-Aspartate Receptor That Causes Autism.

The Up and Down of the N-Methyl-D-Aspartate Receptor That Causes Autism.

Journal: Biological psychiatry

Published: January 22, 2019

Reduction of Movement in Neurological Diseases: Effects on Neural Stem Cells Characteristics.

Reduction of Movement in Neurological Diseases: Effects on Neural Stem Cells Characteristics.

Journal: Frontiers in neuroscience

Published: February 02, 2018

SHANK genes in autism: Defining therapeutic targets.

SHANK genes in autism: Defining therapeutic targets.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: September 05, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026